Condition
Advanced Pancreatic Cancers
Total Trials
4
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Early P 1 (1)
P 1 (1)
P 2 (1)
Trial Status
Recruiting4
Clinical Trials (4)
Showing 4 of 4 trials
NCT07326137Recruiting
A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain
NCT05098197Early Phase 1Recruiting
A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
NCT06770439Phase 2RecruitingPrimary
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
NCT06760364Phase 1RecruitingPrimary
A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer
Showing all 4 trials